Lijuan Chen

[The value of multiplex fluorescence in situ hybridization in the detection of complex karyotypic abnormalities of acute myeloid leukemia].

[Multiple myeloma cell line U266 apoptosis induced by velcade].

[Karyotype analysis in 119 patients with chronic myeloid leukemia at blast crisis].

[Detection of IgVH mutation status in patients with chronic lymphocytic leukemia by multiplex PCR].

[Study of trisomy 22 and inversion 16 in acute myeloid leukemia].

[Molecular genetics in chronic myeloid leukemia with variant Ph translocation].

[Immunophenotyping characteristics of T-cell acute lymphoblastic leukemia].

[Study on molecular cytogenetic abnormalities in multiple myeloma].

Outcome of treatment with Hyper-CVAD regimen in Chinese patients with acute lymphocytic leukemia.

[Multiplex fluorescence in situ hybridization for detecting complex chromosomal aberrations in chronic myeloid leukemia in blast crisis].

Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia.

Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16.

[IgVH mutation status in patients with chronic lymphocytic leukemia].

[Detection of chromosome 13 deletion in plasma cell leukemia by dual-color fluorescence in situ hybridization].

[Fluorescence immunophenotyping and interphase cytogenetics as a tool for the investigation of cytogenetic aberrations of multiple myeloma].

[Correlation between chromosome 13q14 deletion and 1q abnormality in multiple myeloma].

[Analysis of chromosome karyotype abnormality in acute myeloid leukemia].

[Cytogenetic analysis of 362 cases of chronic myeloid leukemia].

[Expression of vascular cell adhesion molecule-1 in patients with multiple myeloma and its significance].

[Role of bone marrow microenvironment in regulation of AP-1 gene expression in multiple myeloma cells].

[Progressive transformation of lymph node germinal centers: a case report and literature review.].

The chromosomal translocation (11;14) (p13; q11) in acute B-Cell lymphocytic leukemia.

[Investigation of the molecular changes in patients with multiple myeloma by fluorescence in situ hybridization].

Identification of the STAT5B-RARα fusion transcript in an acute promyelocytic leukemia patient without FLT3, NPM1, c-Kit and C/EBPα mutation.

Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma.

IRF4 promotes cell proliferation by JNK pathway in multiple myeloma.

[Clinical significance of serum free light chain in patients with multiple myeloma].

[Expression and significance of MUM1/IRF4 in hematological malignancies].

[Clinical analysis of 81 cases of malignant lymphoma treated with autologous hematopoietic stem cell transplantation].

High-dose idarubicin plus busulfan as conditioning regimen to autologous stem cell transplantation: promising post-remission therapy for acute myeloid leukemia in first complete remission?

Haploidentical hematopoietic stem cell transplantation following myeloablative conditioning regimens in hematologic diseases with G-CSF-mobilized peripheral blood stem cells grafts without T cell depletion: a single center report of 38 cases.

[Essential thrombocythemia with JAK2 V617F mutation transformed into acute myeloid leukemia without JAK2 V617F mutation:case report and literature review].

Prognostic value and efficacy evaluation of novel drugs for cytogenetic aberrations in multiple myeloma: a meta-analysis.

Association of MDR1 single-nucleotide polymorphisms and haplotype variants with multiple myeloma in Chinese Jiangsu Han population.

High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma.

[Diagnostic Value of CD27 Antigen in Patients with Multiple Myeloma].

MDR1 polymorphisms affect the outcome of Chinese multiple myeloma patients.

Cereblon: A Protein Crucial to the Multiple Functions of Immunomodulatory Drugs as well as Cell Metabolism and Disease Generation.

Clinical features of multiple myeloma patients with isolated extramedullary relapse.

LncRNAs in ovarian cancer.

The role of miRNAs in the invasion and metastasis of cervical cancer.

Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma.

1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China.

Chimeric antigen receptor T cell therapies for multiple myeloma.

[Correlation of Peripheral Blood T Lymphocyte Subsets with Prognosis of Elderly Patients with Newly Diagnosed Multiple Myeloma].

Low absolute CD4 T cell counts in peripheral blood predict poor prognosis in patients with newly diagnosed multiple myeloma.

[Detection of del(17p13) among newly diagnosed multiple myeloma cases using cytoplasmic light chain immunofluorescence combined with FISH and its clinical significance].

Clinical significance of CD200 expression in newly diagnosed multiple myeloma patients and dynamic changing during treatment.

Survival trends and prognostic factors in patients with solitary plasmacytoma of bone: A population-based study.

The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers.

Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy.

Impact of pre-transplantation minimal residual disease (MRD) on the outcome of Allogeneic hematopoietic stem cell transplantation for acute leukemia.

Anti-tumor activity of a novel proteasome inhibitor D395 against multiple myeloma and its lower cardiotoxicity compared with carfilzomib.

Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study.

Prognostic value of circulating clonal plasma cells in newly diagnosed multiple myeloma.

Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma.

Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study.

Acquired heparin-like anticoagulation process in a patient with multiple myeloma: a case report and literature review.

Baohuoside I Inhibits Tumor Angiogenesis in Multiple Myeloma the Peroxisome Proliferator-Activated Receptor γ/Vascular Endothelial Growth Factor Signaling Pathway.

Acute kidney injury in peripheral blood haploidentical hematopoietic stem cell transplantation: should attract enough attention.

Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma.

LncRNA MEG3 promotes the sensitivity of bortezomib by inhibiting autophagy in multiple myeloma.

Cytopenias following anti-CD19 chimeric antigen receptor (CAR) T cell therapy: a systematic analysis for contributing factors.

Daratumumab, Bortezomib, and Dexamethasone versus Bortezomib and Dexamethasone in Chinese Patients With Relapsed or Refractory Multiple Myeloma: Updated Analysis of LEPUS.

Survival trends and prognostic factors for patients with extramedullary plasmacytoma: A population-based study.

Characteristics and prognostic value of extramedullary chromosomal abnormalities in extramedullary myeloma.

High-risk multiple myeloma predicted by circulating plasma cells and its genetic characteristics.

[The Risk and Survival Analysis of Multiple Malignancies in Hematologic Malignancy Patients: A Single Chinese Center Retrospective Study, 2009 through 2017].

Single-cell transcriptomic atlas throughout anti-BCMA CAR-T therapy in patients with multiple myeloma.

Survival trends and prognostic factors of patients with newly diagnosed multiple myeloma accompanied with extramedullary disease.

An inflammatory response-related gene signature can predict the prognosis and impact the immune infiltration of multiple myeloma.

Real-world prognostic significance of attaining minimal residual disease negativity in newly diagnosed multiple myeloma.

Low serum total cholesterol levels predict inferior prognosis of patients with POEMS syndrome.

[The Prognostic Value of Del(1p32) in Patients with Newly Diagnosed Multiple Myeloma].

Antitumor activity and low gastrointestinal toxicity of a novel selective inhibitor of nuclear export, SZJK-0421, in multiple myeloma.

Mesenchymal stem cell infusion for enhancing hematopoietic recovery and addressing cytopenias in CAR-T cell therapy.